Market Research Logo

Redx Pharma Plc - Product Pipeline Review - 2016

Redx Pharma Plc - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Redx Pharma Plc - Product Pipeline Review - 2016’, provides an overview of the Redx Pharma Plc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Redx Pharma Plc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Redx Pharma Plc
  • The report provides overview of Redx Pharma Plc including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Redx Pharma Plc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Redx Pharma Plc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Redx Pharma Plc’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Redx Pharma Plc
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Redx Pharma Plc’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Redx Pharma Plc Snapshot
Redx Pharma Plc Overview
Key Information
Key Facts
Redx Pharma Plc - Research and Development Overview
Key Therapeutic Areas
Redx Pharma Plc - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Redx Pharma Plc - Pipeline Products Glance
Redx Pharma Plc - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Redx Pharma Plc - Drug Profiles
RDX-001
Product Description
Mechanism of Action
R&D Progress
RDX-002
Product Description
Mechanism of Action
R&D Progress
RDX-003
Product Description
Mechanism of Action
R&D Progress
RDX-004
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit cFMS Kinase for Immunology and Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit DNA Gyrase for Neisseria Gonorrhoeae Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Bacterial Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Hepatitis B
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit IDO for Solid Tumors
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Neuraminidase for Influenza A and B Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Pan-Raf Kinases for Colorectal Cancer
Product Description
Mechanism of Action
R&D Progress
Redx Pharma Plc - Pipeline Analysis
Redx Pharma Plc - Pipeline Products by Target
Redx Pharma Plc - Pipeline Products by Route of Administration
Redx Pharma Plc - Pipeline Products by Molecule Type
Redx Pharma Plc - Pipeline Products by Mechanism of Action
Redx Pharma Plc - Recent Pipeline Updates
Redx Pharma Plc - Dormant Projects
Redx Pharma Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Redx Pharma Plc, Key Information
Redx Pharma Plc, Key Facts
Redx Pharma Plc - Pipeline by Indication, 2016
Redx Pharma Plc - Pipeline by Stage of Development, 2016
Redx Pharma Plc - Monotherapy Products in Pipeline, 2016
Redx Pharma Plc - Partnered Products in Pipeline, 2016
Redx Pharma Plc - Partnered Products/ Combination Treatment Modalities, 2016
Redx Pharma Plc - Preclinical, 2016
Redx Pharma Plc - Discovery, 2016
Redx Pharma Plc - Pipeline by Target, 2016
Redx Pharma Plc - Pipeline by Route of Administration, 2016
Redx Pharma Plc - Pipeline by Molecule Type, 2016
Redx Pharma Plc - Pipeline Products by Mechanism of Action, 2016
Redx Pharma Plc - Recent Pipeline Updates, 2016
Redx Pharma Plc - Dormant Developmental Projects,2016
Redx Pharma Plc, Other Locations
Redx Pharma Plc, Subsidiaries
ist of Figures
Redx Pharma Plc - Pipeline by Top 10 Indication, 2016
Redx Pharma Plc - Pipeline by Stage of Development, 2016
Redx Pharma Plc - Monotherapy Products in Pipeline, 2016
Redx Pharma Plc - Partnered Products in Pipeline, 2016
Redx Pharma Plc - Pipeline by Top 10 Target, 2016
Redx Pharma Plc - Pipeline by Route of Administration, 2016
Redx Pharma Plc - Pipeline by Molecule Type, 2016
Redx Pharma Plc - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report